Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
life sciences
2
×
national blog main
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
aldehyde
alder biopharmaceuticals
aldeyra therapeutics
alexion pharmaceuticals
allergic conjunctivitis
alnylam pharmaceuticals
alopecia areata
amarin
amgen
aridis pharmaceuticals
aristea therapeutics
autoimmune diseases
axitinib
bellus health
biotech
biotech ipos
bolt biotherapeutics
boston
boulder/denver blog main
boulder/denver top stories
bridgebio
bristol-myers squibb
cancer
cell therapy
cidara therapeutics
cigna
concert pharmaceuticals
cvs health
detroit blog main
detroit top stories
diabetes
What
drug
new
2
×
type
2
×
advantages
aldeyra
bar
bio
brings
closer
data
disclosed
expect
eye
fda
fighting
filing
gamble
inflammation
market
medco’s
medicine
mover
multiple
patients
payers
phase
physicians
plan
positive
pricing
puts
results
roundup
sets
step
studies
therapeutics
ubiome
undone
vertex’s
Language
unset
Current search:
type
×
new
×
" life sciences "
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
